VIOLA, FRANCESCO

VIOLA, FRANCESCO  

Dipartimento di Scienze Cliniche e di Comunità  

Mostra records
Risultati 1 - 20 di 139 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis 2024 Nassisi, MarcoBeretta, Gisella BMarelli, LucaLeone, GaiaChighizola, CeciliaCincinelli, GilbertoGiani, TeresaNucci, PaoloViola, FrancescoFilocamo, GiovanniAgostoni, CarloBaldo, FrancescoBaselli, LuciaCosti, Stefania + Article (author) -
Optical coherence tomography angiography findings in Williams-Beuren syndrome 2024 Nassisi, MarcoSperti, AndreaGalmozzi, GuidoAretti, AndreaLeone, GaiaViola, Francesco + Article (author) -
Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma 2023 Leone, GaiaNassisi, MarcoViola, Francesco Article (author) -
Towards a Long-Read Sequencing Approach for the Molecular Diagnosis of RPGRORF15 Genetic Variants 2023 Martella, SalvatoreStaurenghi, GiovanniSalvetti, Anna PaolaViola, Francesco + Article (author) -
Ocular features in Williams-Beuren syndrome: a review of the literature 2023 Nassisi, MarcoAretti, AndreaSperti, AndreaRinaldi, BerardoViola, Francesco + Article (author) -
Vernal Keratoconjunctivitis: A Systematic Review 2023 Bruschi, GaiaCozzi, LauraOsnaghi, SilviaViola, FrancescoMarchisio, Paola + Article (author) -
Update on Retinal Vein Occlusion 2023 Romano, FrancescoLamanna, FrancescaNassisi, MarcoViola, FrancescoStaurenghi, GiovanniInvernizzi, Alessandro + Article (author) -
Delaying anti-VEGF therapy during the COVID-19 pandemic: long-term impact on visual outcomes in patients with neovascular age-related macular degeneration 2023 Nassisi, MarcoPozzo Giuffrida, FrancescoMilella, PaoloViola, Francesco + Article (author) -
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy after Surgical Orbital Decompression 2023 Pirola G.Daga M.Contarino A.Muller I.Arosio M.Viola F.Pignataro L. + Article (author) -
Ten-Year Incidence of Fibrosis and risk factors for its development in Neovascular Age-related Macular Degeneration 2023 Romano, FrancescoCozzi, ElisaAiraldi, MatteoNassisi, MarcoViola, FrancescoAretti, AndreaMilella, PaoloGiuffrida, Francesco PozzoStaurenghi, GiovanniInvernizzi, Alessandro + Article (author) -
Acute retinal pigment epitheliitis is not a diagnostic myth 2023 Viola, Francesco + Article (author) -
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians 2023 Airaldi, MatteoInvernizzi, AlessandroVujosevic, StelaNassisi, MarcoViola, Francesco + Article (author) -
Adaptive Optics of Kyrieleis Plaques in Varicella Zoster Virus-Associated Posterior Uveitis: A Multimodal Imaging Analysis 2023 Milella, PaoloNassisi, MarcoViola, Francesco + Article (author) -
Autoantibodies detection in patients affected by autoimmune retinopathies 2023 Donato K.Colombo L.Rossetti L.Staurenghi G.Salvetti A. P.Oldani M.Placidi G.Viola F.Nassisi M. + Article (author) -
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion 2022 Viola F. + Article (author) -
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 2022 Francesco Viola + Article (author) -
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts 2022 Figus M.Nicolo' M.Viola F.Vujosevic S. + Article (author) -
Quantitative autofluorescence findings in patients undergoing hydroxychloroquine treatment 2022 Parrulli S.Cozzi M.Airaldi M.Romano F.Viola F.Sarzi-Puttini P.Staurenghi G.Invernizzi A. Article (author) -
International impact of the covid-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness Registry 2022 Invernizzi A.Viola F. + Article (author) -
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials 2022 Viola F. + Article (author) -